ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Hypophagia | 19.09.01.004; 14.03.01.006; 07.01.06.010 | 0.004632% | | Not Available |
Lichenoid keratosis | 23.01.01.004 | 0.001158% | | Not Available |
Blood count abnormal | 13.01.07.001 | - | - | Not Available |
Chronic kidney disease | 20.01.03.017 | - | - | |
Pulmonary arterial hypertension | 24.08.03.003; 22.06.01.002 | 0.000906% | | Not Available |
Treatment failure | 08.06.01.017 | - | - | Not Available |
Liver injury | 12.01.02.003; 09.01.07.022 | 0.002895% | | Not Available |
Type 2 diabetes mellitus | 14.06.01.003; 05.06.01.003 | - | - | Not Available |
Oropharyngeal pain | 22.02.05.022; 07.05.05.004 | 0.008685% | | |
Acute kidney injury | 20.01.03.016 | - | - | |
Upper-airway cough syndrome | 22.02.05.030 | 0.004053% | | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | - | - | Not Available |
Hepatic cancer | 16.07.02.004; 09.04.02.008 | 0.000302% | | Not Available |
Pneumocystis jirovecii pneumonia | 22.07.08.009; 11.03.07.005 | 0.000453% | | Not Available |
Faeces soft | 07.01.03.008 | 0.001158% | | Not Available |
Irregular breathing | 22.02.01.026 | 0.000906% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | - | - | |
Anal incontinence | 07.01.06.029; 17.05.01.021 | 0.001158% | | |
Liver function test increased | 13.03.01.044 | 0.011001% | | Not Available |
Abnormal loss of weight | 14.03.02.019 | 0.001158% | | Not Available |
Appendicitis perforated | 11.01.07.028; 07.04.06.011 | 0.001158% | | |
Chronic respiratory failure | 14.01.04.005; 22.02.06.005 | 0.001057% | | Not Available |
Dermatitis exfoliative generalised | 10.01.01.029; 23.03.07.002 | 0.001737% | | Not Available |
Hemiplegic migraine | 24.03.05.012; 17.14.02.004 | 0.001158% | | Not Available |
Jaw cyst | 16.11.03.002; 15.02.04.035 | 0.003474% | | Not Available |
Lung adenocarcinoma | 22.08.01.007; 16.19.01.002 | 0.000604% | | Not Available |
Lung carcinoma cell type unspecified stage IV | 22.08.01.019; 16.19.02.006 | 0.000302% | | Not Available |
Total lung capacity decreased | 13.19.01.013 | 0.004632% | | Not Available |
Terminal state | 08.01.03.079 | 0.001737% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | - | - | Not Available |